Sano
Wellesley, Massachusetts, United States
About Sano
Sano is developing a Point of Care diagnostic platform to early detect and intervene in at least 6 different diseases affecting human and vet populations. Their first focus is human chronic wounds, such as diabetic foot ulcers and venous leg ulcers, personalizing treatment to promote faster healing and avoid over $3B in treatment costs from trial and error and prolonged chronicity. They have tested their proprietary chemistry, have prototypes designed, and soon will start clinical trials and submit for regulatory clearance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $50.0K
- Last round: Grant (Oct 2014)
- Website: sanodx.com
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/sano-2562810 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.